Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:oxazolidinone
gptkb:antibiotic |
| gptkbp:ATCCode |
none (not marketed)
|
| gptkbp:CASNumber |
165800-06-6
|
| gptkbp:developedBy |
gptkb:Pharmacia_&_Upjohn
|
| gptkbp:discoveredIn |
1990s
|
| gptkbp:hasMolecularFormula |
C18H20FN5O5
|
| gptkbp:hasSMILES |
CC(=O)NCC1COC(=O)N1c2cccc(c2F)N3CCOCC3
|
| https://www.w3.org/2000/01/rdf-schema#label |
eperezolid
|
| gptkbp:IUPACName |
N-[[3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide
|
| gptkbp:mechanismOfAction |
protein synthesis inhibitor
|
| gptkbp:PubChem_CID |
CHEMBL19021
5487151 |
| gptkbp:relatedTo |
gptkb:linezolid
|
| gptkbp:status |
not marketed
|
| gptkbp:bfsParent |
gptkb:oxazolidinone
gptkb:oxazolidinones |
| gptkbp:bfsLayer |
7
|